MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
According to a study published by clinical neuroscience in 2000, statistically, each person has a 50 percent chance of experiencing…
Outsourcing
-
-
Industry Viewpoints: Clinical Trials in Asia – Key Considerations
Mainfong Ang is a senior manager in clinical development operations and oversees studies taking place in the East and Southeast…
-
How to Enable Greater Budget Forecasting
It is often said there are two types of budget forecasting, lucky and wrong. The art of true forecasting is…
-
Poor Communication Can Cost You – REALLY Cost You
Believing that because you are telling people things all day long, you are communicating with people can sink you faster…
-
To Outsource or Not to Outsource? That is the Question
As a small to medium-sized company, the decision regarding how to outsource your clinical trial activities requires a fully informed…
-
Execution: A Key Success Factor in All Sponsor-CRO Collaborations
In 2017, the Tufts Center for the Study of Drug Development (Tufts CSDD) estimates that contract research services overtook all…
-
The Stem Cell Emperor’s New Clothes
For some time now, the potential of the global stem cell clinical supply industry has been undermined by a human…
-
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
As Arena International’s Outsourcing in Clinical Trials New England conference gets underway this week in Boston, Massachusetts, Clinical Trials Arena…
-
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
With the clinical trial approval process in Brazil becoming more efficient, patient recruitment and retention is becoming more critical. As…
-
How to Manage Specialist Site Payment Providers
Over the last 10 years, specialized vendors have emerged with technology designed to improve the process of paying clinical sites…
